GW Pharmaceuticals Achieves Positive Results in Phase 2 Proof of Concept Study in Glioma

GW Pharmaceuticals plc , a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform.

QPSI Announces Acquisition Of Pharmaceutical Packaging Company, International Labs

Quality Packaging Specialists International, LLC (QPSI) has acquired 100% ownership of International Labs, LLC (INL) in an equity exchange transaction..

Ovid Therapeutics , NeuroPointDX Announce Collaboration to Identify Biomarkers for Angelman Syndrome

Ovid Therapeutics, a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological disorders, and NeuroPointDX, a biotech company...

Aslan pharmaceuticals announces first patient enrolled in phase 1 study of Varlitinib in japan

ASLAN Pharmaceuticals , a biotech company focused on the development of immunotherapies and targeted agents for Asia prevalent tumour types announced that they are initiating enrolment...

Capsugel Announces Broad Commercial Availability of MAST System

Capsugel, a global leader in delivering high-quality, innovative dosage forms and solutions announced the broad commercial availability of its Modular Automated Sampling Technology (MAST) system.

Aurobindo Pharma buys four biosimilar drugs from TL Biopharmaceutical

Aurobindo Pharma Limited is pleased to announce the acquisition of four cell culture derived biosimilar products from TL Biopharmaceutical AG. As part of this agreement.

For Advertising Queries:

Please e-mail : kathryn@worldpharmatoday.com
or
call to: + 91 88268 49084

If you like to receive our latest Media Pack 2017 / Editorial Calender please click here

For the latest visit: www.worldpharmatoday.com